INVEGA cpr ret 3 mg 28 pce

7680579610010 CH-57961 N05AX13 01.05.0.

Active substances:

INVEGA cpr ret 3 mg 28 pce
INVEGA cpr ret 3 mg 28 pce
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5796101
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
paliperidonum 3 mg, polyethyleni oxidum, natrii chloridum corresp. natrium 11.8 mg, povidonum K 29-32, acidum stearicum, E 172 (rubrum), E 321, Überzug: hydroxyethylcellulosum, macrogolum 3350, cellulosi acetas, hypromellosum, lactosum monohydricum 13.2 mg, triacetinum, cera carnauba, E 171, Drucktinte: hypromellosum, propylenglycolum, E 172 (nigrum), pro compresso obducto.

Articles (1)

Invega 3 mg, Retardtabletten
Tabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
04/01/2023
Professional SmPC
Français
04/01/2023
Professional SmPC
Italien
04/01/2023
Patient information leaflet
Allemand
19/04/2021
Patient information leaflet
Français
19/04/2021
Patient information leaflet
Italien
19/04/2021

Detailed composition

Substance Quantity Type Category
paliperidonum
3.0 MG Substance Wirkstoff (Principe actif)
polyethyleni oxidum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrium
11.8 MG Substance HBESI
povidonum K 29-32
- Substance HNIDK
acidum stearicum
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
E 321
- Substance ANTOX
hydroxyethylcellulosum
- Substance HNIDK
macrogolum 3350
- Substance HNIDK
cellulosi acetas
- Substance HNIDK
hypromellosum
- Substance HNIDK
lactosum monohydricum
13.2 MG Substance HBESI
triacetinum
- Substance HNIDK
cera carnauba
- Substance HNIDK
E 171
- Substance FNIDK
hypromellosum
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 172 (nigrum)
- Substance FTODK

Reimbursement information

Public price
CHF 130.00
Specialties list
Yes
Generic
No
SL addition date: 01/07/2008

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
57961
Drug name
Invega, Retardtabletten
Galenic form
FILM
ATC Code
N05AX13
Authorization status
Z
Dispensation category
B
First authorization
15/05/2008
Authorization expiration date
31/12/9999
IT number
01.05.0.
Domain
Human medicine
Field of application
Neuroleptikum

Packaging details

Description (FR)
INVEGA cpr ret 3 mg 28 pce
Description (DE)
INVEGA Ret Tabl 3 mg 28 Stk
Market launch
15/05/2008
Narcotic (BTM)
No

Available generics

Paliperidon-Mepha retard, Retardtabletten
CHF 120.25
View
Paliperidon-Mepha retard, Retardtabletten
CHF 120.25
View
Paliperidon-Mepha retard, Retardtabletten
CHF 159.50
View
Paliperidon Sandoz, Retardtabletten
CHF 120.25
View
Paliperidon Sandoz, Retardtabletten
CHF 120.25
View
Paliperidon Sandoz, Retardtabletten
CHF 159.50
View
Paliperidon Spirig HC retard, Depot-Injektionssuspension in einer Fertigspritze
CHF 91.10
View
Paliperidon Spirig HC retard, Depot-Injektionssuspension in einer Fertigspritze
CHF 138.90
View
Paliperidon Spirig HC retard, Depot-Injektionssuspension in einer Fertigspritze
CHF 186.40
View
Paliperidon Spirig HC retard, Depot-Injektionssuspension in einer Fertigspritze
CHF 224.60
View

Other packaging sizes

INVEGA cpr ret 6 mg 28 pce
28 TABL
View
INVEGA cpr ret 9 mg 28 pce
28 TABL
View
Buy us a coffee Explore the data